Vilsbøll, T, Zdravkovic, M, Le-Thi, T, Krarup, T, Schmitz, O, Courrèges, J-P, Verhoeven, R, Bugànová, I & Madsbad, S 2007, ' Liraglutide, a long-acting human GLP-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes mellitus ', Diabetes Care, vol. 30(6), pp. 1608-10 .